ARTICLE | Clinical News
Clolar clofarabine regulatory update
June 5, 2006 7:00 AM UTC
EC approved Evoltra clofarabine to treat acute lymphoblastic leukemia (ALL) in pediatric patients who have relapsed or are refractory to at least 2 prior regimens. GENZ markets the second-generation p...